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 Variability of Serum Markers of Erythropoiesis during 
6 Days of Racing in Highly Trained Cyclists
(MCH) and mean corpuscular haemoglobin con-
centration (MCHC)  [ 32 ] .
 Currently only abnormalities in Hb and OFF-
Score (calculation based on Hb and Ret %) are 
taken into consideration for sanctioning athletes, 
while the other parameters are used by a panel of 
independent experts to gain additional informa-
tion about possible pathological conditions of the 
athlete or altered sample quality.
 The current passport model could be improved 
with additional markers, however, since inclu-
sion markers require robust and standardized 
measurement procedures reaching a forensic 
level of quality. It is obvious that potential new 
markers must also be highly sensitive to the use 
of ESAs. Information on the variation of the cho-
sen biomarkers under diﬀ erent conditions and in 
diﬀ erent populations is also required.
 The variables total protein (TP), albumin (Alb), 
soluble transferrin receptor (sTfR) and ferritin 
(Fer) are routinely used in medical screenings for 
which fully automated and highly standardised 
 Introduction
 ▼
 The use of erythropoiesis-stimulating agents 
(ESAs) such as recombinant human erythropoie-
tin (rhEPO), hypoxia-inducible factor (HIF) stabi-
lizers, methoxy polyethylene glycol-epoetin beta 
(CERA) or other substances with similar chemical 
structure or biological eﬀ ects is banned by the 
World Anti-Doping Agency (WADA)  [ 38 ] .
 While there are already direct detection methods 
available for many substances (i. e., rhEPO), the 
haematological module of the athlete biological 
passport (ABP) provides the opportunity to 
potentially detect the abuse of new substances 
and methods which are possibly unknown to 
anti-doping agencies. This indirect, longitudinal 
approach which is based on monitoring biomark-
ers of altered erythropoiesis combines haemat-
ocrit (Hct), haemoglobin (Hb), red blood-cell 
count (RBC), reticulocyte percentage (Ret %), 
reticulocyte count (Ret#), mean corpuscular vol-
ume (MCV), mean corpuscular haemoglobin 
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 Abstract
 ▼
 The athlete biological passport for the fi ght 
against doping is currently based on longitudinal 
monitoring for abnormal changes in cellular 
blood parameters. Serum parameters related to 
altered erythropoiesis could be considered for 
inclusion in the passport. The aim of this study 
was to quantify the changes in such parameters 
in athletes during a period of intense exercise.
 12 highly trained cyclists tapered for 3 days 
before 6 days of simulated intense stage racing. 
Morning and afternoon blood samples were 
taken on most days and analysed for total pro-
tein, albumin, soluble transferrin receptor and 
ferritin concentrations. Plasma volume was 
determined via total haemoglobin mass meas-
ured by carbon-monoxide rebreathing. Percent 
changes in means from baseline and percent 
standard errors of measurement (analytical error 
plus intra-athlete variation) on each measure-
ment occasion were estimated with mixed linear 
modelling of log-transformed measures.
 Means of all variables changed substantially in 
the days following the onset of racing, ranging 
from  − 13 % (haemoglobin concentration) to  + 27 % 
(ferritin). After the second day, errors of measure-
ment were generally twice those at baseline.
 Plasma variables were aﬀ ected by heavy exercise, 
either because of changes in plasma volume 
(total protein, albumin, haemoglobin), acute 
phase/infl ammatory reactions (ferritin) or both 
(soluble transferrin receptor). These eﬀ ects need 
to be taken into consideration when integrating a 
plasma parameter into the biological passport 
model for athletes.
Aﬃ  liations Aﬃ  liation addresses are listed at the end of the article
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measurement systems are available which help guarantee the 
validity and robustness of the results. It has been speculated in 
various studies  [ 2 ,  4 ,  8 ] that these markers can be used to detect 
altered erythropoiesis in trials where rhEPO was administered. 
Notably, in one double-blind, placebo controlled study  [ 4 ] sTfR 
increased signifi cantly after 1 week of EPO treatment. The same 
study also showed an increase of the sTfR/Fer ratio, with both 
changes remaining elevated for 1 week post treatment  [ 4 ] .
 In another study on the eﬀ ects of EPO in athletes and a possible 
indirect detection in doping control, the authors proposed the 
use of the sTfR/TP ratio. They argued that iron supplementation 
makes Fer an unsuitable marker and that the inclusion of TP can 
be used to adjust for changes in haemoconcentration, which 
would also be the case for Alb  [ 2 ] . Furthermore, the intra-indi-
vidual and day-to-day variation of these parameters have been 
assessed in several studies  [ 5 ,  7 – 9 ,  25 ] , however samples were 
collected from healthy subjects and not athletes who were 
exposed to intense, high volume exercise.
 While information on the infl uence of gender and age is also 
available from many medical publications, the information on 
the variation of these markers in highly trained athletes during 
periods of heavy exercise is scarce  [ 1 ,  30 ] . An important factor 
contributing to variability of concentrations of blood constitu-
ents is plasma volume (PV). Variations in PV are particularly 
important in athletes, as changes in their level of physical activ-
ity can induce variations in PV of up to 25 %, with resulting simi-
lar changes in plasma concentrations  [ 6 ,  13 ,  15 ,  21 ,  22 ,  28 ] . The 
aim of this study was therefore to monitor changes in PV and 
concentrations of markers in blood that could be used in tests for 
indirect detection of ESAs in a group of highly trained cyclists 
taking part in a stage race.
 Methods
 ▼
 Subjects
 The study was conducted according to the ethical standards out-
lined in the declaration of Helsinki and approved by the Ethics 
committee of the University of Freiburg, Germany  [ 16 ] . The par-
ticipants were 12 healthy male Caucasian amateur cyclists, who 
fi rst underwent a full medical check-up with anthropometry to 
exclude pathological conditions before performing an incremen-
tal cycling test until exhaustion for the determination of their 
maximal oxygen uptake (VO 2 max). Their anthropometric, fi t-
ness and simple haematological data are presented in   ●  ▶   Table 1 .
 Cycling intervention
 The investigation took place in Qatar. To mimic a real training 
and competition regime, the subjects underwent 3 days of 
reduced training after the air travel from Germany to Qatar, fol-
lowed by a 6-day cycling stage race simulation. The simulated 
cycling stage race was designed to be as close to a real race as 
possible and required certain tasks to be performed by the par-
ticipants every day additional to or partly replacing the 3–4 h of 
daily road cycling. Special primes were available as incentive to 
fulfi l the daily goals.   ●  ▶   Table 2 presents the information on the 
stages of the 6 exercise days including distance, specifi c tasks 
and ambient temperature during exercise.
 Blood sampling
 Venous blood sampling was performed according to the current 
WADA guidelines for the ABP (blood sampling)  [ 37 ] . Blood was 
drawn in a sitting position with the subjects having remained 
seated for at least 10 min to avoid fl uctuations in PV. Sampling 
took place every morning at 8:00 a.m. before breakfast and every 
evening at 6:00 p.m., which was at least 2 h post exercise. A 
 volume of 11.7 ml of blood was obtained on each occasion (one 
2.7 ml EDTA tube (Sarstedt, Numbrecht, Germany) and one 
9.0 ml tube with clot activator (S-Monovette, Sarstedt, Numbrecht, 
Germany)).
 Haemoglobin mass and plasma volume
 To investigate PV eﬀ ects, Hb mass was measured using the 
 optimised CO rebreathing method as previously described by 
Schmidt and Prommer  [ 29 ] . Hb mass was measured in duplicate 
in each subject at the beginning of the study. The true Hb mass 
was calculated for each time point taking into account the exact 
loss of Hb due to blood sampling. Plasma volume for each sam-
pling time point was then calculated from Hb mass, Hb concen-
tration and Hct (see calculations and statistics). Reticulocyte 
percentage, tested daily to prevent a misinterpretation of our 
data caused by an increased Hb synthesis, did not show any 
changes. The analytical error of measurement of the Hb mass 
measurements calculated from the duplicate measures was 2.3 % 
 [ 18 ] .
 Haematological parameters
 The EDTA blood samples were analysed within 90 min of collec-
tion on a Sysmex XT-2000i haematology analyser (Sysmex Corp., 
Kobe, Japan) according to WADA guidelines. The analytical error 
of measurement as a coeﬃ  cient of variation for Hb and Hct were 
0.3 % and 0.4 % respectively.
 Table 1  Characteristics of the 12 athletes. Data are mean ± SD. 
 age (y)  27.0 ± 2.3 
 mass (kg)  69.7 ± 4.3 
 height (cm)  181.0 ± 9.7 
 body mass index (kg.m -2 )  21.4 ± 1.5 
 body fat ( %)  12.9 ± 2.3 
 VO 2 max (ml.kg -1 .min -1 )  63.8  ± 5.7 
 haemoglobin (g.dL -1 )  14.8 ± 0.7 
 haematocrit ( %)  42.9 ± 2.3 
 haemoglobin mass (g)  864 ± 81 
 Table 2  Information about the simulated race stages. 
  Stage 1  Stage 2  Stage 3  Stage 4  Stage 5  Stage 6 
 study day  4  5  6  7  8  9 
 distance (km)  124  136  152  152  45  124 
 duration (h)  3:22  4:00  4:14  4:12  0:49  4:05 
 special tasks  3 sprints  time-trial  –  3 sprints  time trial  criterium 
 ambient temperature ( °C)  27  24  23  24  25  27 
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 Serum parameters
 The sera samples were centrifuged within 30 min after collec-
tion, aliquoted and stored at  − 20 °C for batch analysis. All param-
eters were then analysed 4 weeks after the study on a Roche 
Cobas Integra 400 plus analyser (Roche, Mannheim, Germany). 
The analytical error of measurement, estimated in an in-house 
validation study, was 0.9 % for TP, 1.3 % for Alb, 2.0 % for sTfR and 
5.1 % for Fer.
 All samples were analysed for TP and Alb. However, due to rea-
gent costs sTfR and Fer were analysed for all morning samples 
but not for all evening samples. Evening sTfR analysis was per-
formed on Days 1, 2, 6, 8, while for Fer evening samples were 
tested on Days 1, 2, 6, 7, 8.
 Calculations
 Hb mass was calculated on the assumption that the mean of the 
2 Hb mass tests on Days 2 and 3 of the study represented a stable 
initial value. Every time blood was sampled the corresponding 
Hb mass was calculated using the following formula:
 Actual Hb mass (g) = last Hb mass (g) – (0.117 × measured Hb 
(g.dl  − 1 )).
 The factor 0.117 was used to correct for the 11.7 ml drawn dur-
ing each blood sample. Assuming a random error of as much 
as  ± 1 ml at each withdrawal, the accumulated error after 12 
withdrawals by the last withdrawal of the stage race would 
be  ± 1 × √12 =  ± 3.5 ml; for a Hb concentration of 15 g.dl  − 1 and 
fi nal Hb mass of 840 g, the resulting error in Hb mass would 
be  ± 0.5 g or 0.06 %, which is negligible compared with the 
observed errors of measurement for blood parameters.
 Statistics
 The aim of the analysis was to estimate the systematic bias and 
random error for measurements of specifi c blood parameters 
during periods of intense exercise, such as cycling stage racing. 
The errors of measurement were estimated to include analytical 
error and real intra-subject (or biological) changes, because 
these are the errors that a practitioner or researcher has to con-
tend with when tracking changes in an individual or group. The 
last 2 morning measurements before the fi rst race (i. e., the 
mornings of Days 3 and 4) were used as a stable baseline for the 
estimation of error of measurement (intra-subject variability) at 
other measurement times. Changes in the mean at other times 
were calculated as changes from the morning of Day 4. (For sTfR, 
Days 2 and 3 were chosen as baseline, and changes in means 
were calculated from Day 3, owing to greater error on the morn-
ing of Day 4). A separate analysis was performed for each of the 
other days of measurements by including it in a mixed linear 
model with the 2 baseline days.
 The analyses were realized with Proc Mixed in the Statistical 
Analysis System (Version 9.2, SAS Institute, Cary NC). The only 
fi xed eﬀ ect in the model had 6 levels to estimate the mean of the 
parameter on each morning (pre-racing) and afternoon (post-
racing) of the 3 days. The random eﬀ ects were cyclist identity (to 
estimate each cyclist’s mean), interactions of cyclist identity 
with dummy variables having values of 1 for each afternoon of 
the 2 baseline days and for the morning and afternoon of the 
other day and 0 otherwise (to estimate extra measurement error 
at those measurement times) and the residual (to estimate error 
of measurement in the baseline morning measurements). The 
error of measurement (intra-subject variability) at times other 
than morning baseline was estimated by adding the residual 
variance to the corresponding extra variance and taking the 
square root. Negative values for the extra variance were permit-
ted for the purpose of properly allowing for the possibility that 
sampling variation could result in errors of measurement 
smaller on the afternoons of baseline days and on the other days 
than those on baseline mornings. The error of measurement at 
baseline was estimated by taking the square root of the mean of 
the residual variance from all analyses. An estimate of the stand-
ard deviation of change scores between 2 baseline tests and 
between a baseline test and the test with maximum error was 
derived by adding the error variances of the 2 tests and taking 
the square root.
 Changes in the mean and errors of measurement were expressed 
in per cent units by back-transformation following analysis of 
the log-transformed values of the parameter  [ 19 ] . The appropri-
ateness of log transformation for each dependent variable was 
checked by inspection of plots of residual vs. predicted values, 
which showed no evidence of non-uniformity. Confi dence limits 
for changes in the mean were provided by the mixed modelling 
procedure. Confi dence limits for the errors of measurement 
were approximations based on the assumption that the sam-
pling distribution of their variances was normal. Outcomes were 
assessed inferentially on the basis of the uncertainty repre-
sented by the confi dence interval  [ 19 ] .
 Results
 ▼
 The mean changes and errors of measurement (intra-subject 
variability) in blood parameters over the duration of the study 
are shown in   ●  ▶   Fig. 1 .   ●  ▶   Table 3 shows the baseline mean and 
standard deviations of the parameters as well as measures rele-
vant to testing for changes in individual athletes: the maximum 
changes in the means between a baseline test and test during the 
stage race, the standard deviations of change scores between 
tests at baseline, and the maximum standard deviations of 
change scores between a baseline test and a test during the stage 
race. Given the uncertainty in the estimates (95 % confi dence 
limits), all of the maximum mean changes were clearly substan-
tial, and most of the maximum standard deviations of change 
scores were clearly greater than those at baseline.
 Discussion
 ▼
 All the measured sera variables were aﬀ ected substantially by 
the stage race. The magnitude of the change varied between the 
parameters, as illustrated in   ●  ▶   Fig. 1 . The PV showed a small 
decrease during the tapering period, followed by an increase 
during the race days. Timelines for morning and evening were 
very similar with the exception of a small drop on Day 9 for the 
evening values. Total protein, Alb and sTfR showed a continuous 
decrease for the morning values. Ferritin started to increase 
from Day 5 and decreased again after Day 7. All parameters also 
showed a substantial increase in the standard error of measure-
ment (intra-subject variability), starting from the third race day 
(Day 6). The maximum error occurred between the third and 
sixth race day, depending on the parameter.
 In   ●  ▶   Fig. 1 there is an apparent relationship between high PV 
and high standard error. Interestingly the standard error for Alb 
on Day 1 is also relatively high. A possible reason might be the 
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residual eﬀ ect of the air travel, which could have stimulated 
albumin synthesis as described by Imoberdorf et al.  [ 20 ] . In their 
study an increase in absolute synthesis rate and Alb concentra-
tion was observed in a group of subjects who were transported 
by helicopter to an altitude of 4 500 m. Imoberdorf et al.  [ 20 ] 
speculated that the increase in Alb synthesis could result from 
respiratory alkalosis, which would compensate for the negative 
eﬀ ects of hypoxia on protein biosynthesis. Another reason could 
be the infl uence of the PV.   ●  ▶   Fig. 1 shows that the standard error 
for PV was also higher for Day 1 when compared to Days 2 and 3. 
The PV can be aﬀ ected by hydration, and as Alb regulates the BV 
by maintaining the oncotic pressure, this could provide another 
explanation for the higher error.
 The increase in the error for the PV can be explained by indi-
vidual adaptations to the stage racing and to the environmental 
conditions with on average 17 °C higher temperatures than in 
the country of origin. Both exercise and thermoregulation are 
known to increase PV  [ 14 ] . Due to the characteristics of a cycling 
competition, the workload of the subjects was not standardized 
as in a laboratory investigation, and thus diﬀ erences related to 
the individual daily form, eﬀ ort, strategy and motivation may 
have also infl uenced this error. However,   ●  ▶   Fig. 1 clearly demon-
strates the increase of the PV during the Race Days (Days 4–9). 
The diurnal variation in PV, which can be observed in   ●  ▶   Fig. 1 , is 
also in agreement with previous studies  [ 26 ,  36 ] . This variation 
is mirrored by an increase of Hb concentration and Hct (not 
shown) due to dehydration overnight. The increase in total PV 
seems however not to aﬀ ect this diurnal rhythm  [ 13 ] . As Hb is a 
parameter that is already used in anti-doping, our data on the 
dependence of the Hb concentration on plasma volume changes 
(  ●  ▶   Fig. 1 ,   ●  ▶   Table 3 ) also highlight one of the biggest challenges 
in this endeavour: interpretation of an individual biological pro-
fi le must take into account the recent training and competition 
experience of the athlete. Currently WADA is addressing this 
issue in their sampling reports, and there are a limited number 
of specialists who perform these interpretations.
 The mean changes of TP and Alb were below 5 %. The reduction 
during the Race Days demonstrated in   ●  ▶   Fig. 1 could be mainly 
due the PV expansion. However, as Alb is also a negative acute 
phase protein another possible reason could be exercise-induced 
infl ammatory processes  [ 20 ] . This hypothesis fi nds support 
in   ●  ▶   Fig. 1 , which shows a mean increase of Fer during the race 
of ~20 %. Ferritin is also a positive acute phase protein that is up-
regulated with infl ammation  [ 35 ] . As all subjects were healthy 
and not iron defi cient, an increase in Fer caused by changes in 
nutrition can be excluded.
 Total protein has been proposed in several studies as a marker to 
correct for PV changes  [ 2 ,  33 ] . While this approach might pro-
vide valid results in highly standardized non-exercise settings 
for measurements within a few hours, our results show that it is 
not possible to use this parameter in an anti-doping context over 
a period of several days. Both TP and Alb showed a time course 
that did not closely follow the time course of PV. During the later 
stages of the study both of these parameters showed an incon-
sistency in their values within the same day as well as an 
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 Fig. 1  Mean changes 
in blood parameters on 
the mornings (●) and 
afternoons (○) of the 
study period relative to 
the mean on the last 
test prior to racing (the 
morning of Day 3 for 
sTfR and Day 4 for all 
other variables). The 
dashed line is the refer-
ence line indicating no 
change, and the bars 
are standard errors of 
measurement (intra-
subject variability). 
Days 1–3 were travel 
or rest days. The stage 
race took place from 
Days 4–9. 
 Table 3  Means and SD of blood parameters at baseline, and changes in values relevant to blood testing (with 95 % confi dence limits) derived from the data 
in   ●  ▶   Fig. 1 : maximum changes in the means during the stage race, standard deviations of change scores between baseline tests, and maximum standard devia-
tions of change scores between a baseline test and a test during the stage race.  
  Baseline (mean  ± SD)  Maximum change in mean ( %)  Baseline SD of change scores ( %)  Maximum SD of change scores ( %) 
 plasma volume  3.34 ± 0.45 L  + 24;  ± 5  4.9;  ± 2.3  8.4;  ± 4.0 
 haemoglobin  148.0 ± 6.6 g.L  − 1  − 13;  ± 2.2  2.8;  ± 1.3  5.1;  ± 2.5 
 total protein  69.7 ± 4.6 g.L  − 1  − 4.8;  ± 2.7  4.5;  ± 1.4  5.9;  ± 2.6 
 albumin  47.0 ± 2.2 g.L  − 1  − 4.1;  ± 2.0  3.7;  ± 1.3  4.7;  ± 2.3 
 ferritin  77 ± 51 ng.ml  − 1  + 27;  ± 14  11.6;  ± 5.9  30;  ± 16 
 sTfR  2.75 ± 0.62 mg.L  − 1  − 10;  ± 3.4  5.8;  ± 3.0  9.7;  ± 4.7 
 sTfR, soluble transferrin receptor 
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increase in error with the change in PV due to exercise. Total 
protein for example shows higher mean values in the morning 
than in the evening on some days (i. e., Days 6 and 7) and the 
opposite on others days (i. e., Days 8 and 9). Immunological proc-
esses during an infection, which down-regulate Alb or increase 
the TP concentration by the production of immunoglobulin 
must also be kept in mind.
 Another marker which we investigated was Fer. Ferritin is highly 
aﬀ ected by the abuse of rhEPO and by blood transfusion. In such 
settings, Fer will typically decrease during abuse of ESAs or fol-
lowing blood withdrawal and increase after blood transfusion. 
Although it can easily be infl uenced by iron supplementation, it 
is nevertheless a marker with a high sensitivity for blood manip-
ulation. Our study highlights however the role of Fer as an acute 
phase protein, as discussed above  [ 11 ,  12 ,  34 ] . Ferritin increased 
with on-going race duration up to Day 7. While a decrease was 
then observed starting from Day 8, the mean values remained 
higher when compared to the Resting Days. The decrease could 
have resulted from a combination of declining infl ammatory 
processes and/or an increased iron demand. Harris et al.  [ 17 ] 
stated that one of the main requirements of a biological marker 
for longitudinal follow ups is that the intra-individual variability 
should be lower than the corresponding inter-individual varia-
bility. In the current literature for biological variation, the inter-
subject biologic variation of Fer is listed with 15.0 % while the 
intra-subject variation has a value of 14.2 %  [ 27 ] . In our study we 
saw an increase in error from 8.2 % during the resting period to 
nearly 30 % as a result of high-intensity and high-volume exer-
cise. Thus, from a purely mathematical point of view, Fer has 
certain limitations as a future marker for the haematological 
module of the ABP during periods of high intensity exercise. On 
the other hand its high sensitivity for blood manipulation has 
been reported in several studies, and the magnitude of changes 
in Fer observed after typical blood manipulations such as blood 
withdrawal and reinfusion are usually much higher than those 
induced by exercise  [ 3 ] . Furthermore, the direction of changes 
(increase/decrease) is an element of interpretation depending 
on the timing of the blood test in relation to the training and 
competition schedule of the athlete. Therefore, Fer might add 
valuable information in the hands of skilled experts who are 
able to discern infl ammatory and exercise related eﬀ ects from 
the results of blood manipulation.
 The most stable marker in our study was the sTfR, the circulat-
ing, proteolytic product of the transferrin receptor that is 
expressed on cells depending on the iron demand and rate of 
erythropoiesis. The sTfR concentration in plasma is proportional 
to the cellular transferrin receptor. As demonstrated in   ●  ▶   Fig. 1 , 
the time course of the sTfR morning values during our study 
seems to be inversely related to the time course of the PV (i. e., 
when the PV increases, the sTfR concentration decreases). As 
described in several studies, sTfR is not infl uenced by infl amma-
tion  [ 1 ,  23 ,  24 ,  30 ] , and thus a potential increase in concentra-
tions during periods of heavy exercise would either refl ect a 
possible dehydration or an increase in erythropoiesis. One 
shortcoming of our study in this context was the lack of regular 
daily evening measurements. We do not have an explanation for 
the slightly higher values in the evening of Day 6 and 8. We can 
only presume that the diﬀ erence in the error might be related to 
the exercise load on these days or due to analytical batch varia-
bility of the reagents. Abellan et al.  [ 1 ] reported the inter-assay 
variability for the assay used in our study as below 2 %, which is 
relatively low. We did not fi nd information in the literature that 
sTfR exhibits a signifi cant diurnal variation. While Schumacher 
et al. also demonstrated that immediate exercise has no signifi -
cant eﬀ ect on the transferrin receptor  [ 30 ] , Abellan et al. 
reported a signifi cant increase of sTfR after a 21-km running 
race but not after a 10-km race. Therefore, the accumulation of 
exercise load during our study or the time of blood sampling (2 h 
after exercise) perhaps had an infl uence on the sTfR values. In 
our study we found a change in the error from 4.4 % at baseline 
to 8.1 % during the stage race simulation, which is still much 
lower compared to an inter-individual variation of 35 % which 
we observed in a reference population of 200 adolescent athletes 
(unpublished data). The 8.1 % variability we reported is also in 
line with the data of Abellan who found an intra-athlete variabil-
ity of 9 % when analysing blood samples of athletes from diﬀ er-
ent sports over the period of a complete training and competition 
season  [ 1 ] . Due to its relatively low variability, sTfR seems to be 
a possible candidate for the inclusion in the haematological 
module of the biological passport. Another advantage of this 
marker in serum is suﬃ  cient stability for changes that occur 
during transport of samples to be negligible  [ 10 ] . However 
before implementation, it would have to be decided which ana-
lytical technique should be applied for the analysis of the sTfR, 
as the lack of standardization in the analysis of this parameter is 
still an issue and might cause diﬀ erences in analytical results 
between laboratories.
 Conclusion
 ▼
 Nearly all of the plasma variables assessed were signifi cantly 
aﬀ ected by heavy exercise. This can be either related to PV-asso-
ciated processes (TP, Alb) or to acute phase/infl ammatory reac-
tions (Fer) or both. However the same dependence on PV is also 
relevant for Hb, which is already one of the key parameters in 
the blood passport. Thus before integrating a new plasma 
parameter into the Athletes Biological Passport model, the 
described eﬀ ects need to be taken into consideration.
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